Nutropin
Company: Genentech
Approval Status: Approved December 1997
Treatment for: growth hormone deficiency
Areas: Endocrinology
Possible similar drugs: Nutropin
General Information
Other Useful Resources
The liquid formulation of Nutropin (somatropin injection) has been approved for the replacement of endogenous growth hormone in adult patients with growth hormone deficiency. The product is currently indicated for pediatric growth hormone deficiency and chronic renal insufficiency.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
